Search research articles
Contact Us
Filters
Showing results (1-10 of 42) with videos related to
Page
of 5
Sort By:
Farmaco (Societa Chimica Italiana : 1989)
|
August 1, 1993
N-arylpiperazinyl derivatives of 2,3-dihydrobenzoxazin[1,4]-3-ones synthesis and normolipemic activity
P Depreux, Z Moussavi, D Lesieur, et al.
The Journal of Pharmacy and Pharmacology
|
August 2, 2001
Conformational analysis of tripeptide Ac-Lys-Pro-Val-NH2, COOH-terminal sequence of alpha-MSH
P Chavatte, S Yous, D Lesieur, et al.
Journal of Medicinal Chemistry
|
September 21, 2001
Three-dimensional quantitative structure-activity relationships of cyclo-oxygenase-2 (COX-2) inhibitors: a comparative molecular field analysis
P Chavatte, S Yous, C Marot, et al.
European Journal of Drug Metabolism and Pharmacokinetics
|
January 1, 1981
Gas-chromatographic determination of levamisole in human plasma-normalization and reliability of the method
F Rousseau, J M Haguenoer, D Lesieur, et al.
Free Radical Biology & Medicine
|
July 13, 1999
Structure-activity relationships in a series of melatonin analogues with the low-density lipoprotein oxidation model
A Gozzo, D Lesieur, P Duriez, et al.
British Journal of Pharmacology
|
January 1, 1995
S14080, a peripheral analgesic acting by release of an endogenous circulating opioid-like substance
S H Ferreira, B B Lorenzetti, M Devissaguet, et al.
Therapie
|
January 28, 1999
[Melatonin, a pertinent prototype for therapeutic innovation]
D Lesieur, V Leclerc, P Chavatte, et al.
Methods and Findings in Experimental and Clinical Pharmacology
|
November 1, 1984
Antimicrotubular effects of ethacrynic acid
M L Mallevais, A Delacourte, M Luyckx, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
March 15, 1989
Lipid lowering actions of 7-(2-methylene butyryl)-(2H)-1,4-benzoxazin-3-(4H)-one derivatives in mice, rats and Syrian hamsters
Z Moussavi, M O Plancke, P Olivier, et al.
Brain Research
|
June 3, 1999
A single oral dose of S 22153, a melatonin antagonist, blocks the phase advancing effects of melatonin in C3H mice
L Weibel, M C Rettori, D Lesieur, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 42) with videos related to
Sort By:
Page
of 5
Farmaco (Societa Chimica Italiana : 1989)
|
August 1, 1993
N-arylpiperazinyl derivatives of 2,3-dihydrobenzoxazin[1,4]-3-ones synthesis and normolipemic activity
P Depreux, Z Moussavi, D Lesieur, et al.
The Journal of Pharmacy and Pharmacology
|
August 2, 2001
Conformational analysis of tripeptide Ac-Lys-Pro-Val-NH2, COOH-terminal sequence of alpha-MSH
P Chavatte, S Yous, D Lesieur, et al.
Journal of Medicinal Chemistry
|
September 21, 2001
Three-dimensional quantitative structure-activity relationships of cyclo-oxygenase-2 (COX-2) inhibitors: a comparative molecular field analysis
P Chavatte, S Yous, C Marot, et al.
European Journal of Drug Metabolism and Pharmacokinetics
|
January 1, 1981
Gas-chromatographic determination of levamisole in human plasma-normalization and reliability of the method
F Rousseau, J M Haguenoer, D Lesieur, et al.
Free Radical Biology & Medicine
|
July 13, 1999
Structure-activity relationships in a series of melatonin analogues with the low-density lipoprotein oxidation model
A Gozzo, D Lesieur, P Duriez, et al.
British Journal of Pharmacology
|
January 1, 1995
S14080, a peripheral analgesic acting by release of an endogenous circulating opioid-like substance
S H Ferreira, B B Lorenzetti, M Devissaguet, et al.
Therapie
|
January 28, 1999
[Melatonin, a pertinent prototype for therapeutic innovation]
D Lesieur, V Leclerc, P Chavatte, et al.
Methods and Findings in Experimental and Clinical Pharmacology
|
November 1, 1984
Antimicrotubular effects of ethacrynic acid
M L Mallevais, A Delacourte, M Luyckx, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
March 15, 1989
Lipid lowering actions of 7-(2-methylene butyryl)-(2H)-1,4-benzoxazin-3-(4H)-one derivatives in mice, rats and Syrian hamsters
Z Moussavi, M O Plancke, P Olivier, et al.
Brain Research
|
June 3, 1999
A single oral dose of S 22153, a melatonin antagonist, blocks the phase advancing effects of melatonin in C3H mice
L Weibel, M C Rettori, D Lesieur, et al.
Page
of 5